• 1. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 2. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 3. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 4. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 5. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219

Introduction to 2-(Quinolin-3-yl)propanoic Acid (CAS No. 1247842-46-1)

2-(Quinolin-3-yl)propanoic acid (CAS No. 1247842-46-1) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique quinoline moiety and propanoic acid functional group, exhibits a range of biological activities that make it a valuable candidate for various therapeutic applications.

The chemical structure of 2-(Quinolin-3-yl)propanoic acid consists of a quinoline ring attached to a propanoic acid chain. The quinoline ring, a heterocyclic aromatic compound, is known for its diverse biological properties, including antimalarial, anticancer, and anti-inflammatory activities. The propanoic acid group, on the other hand, confers the compound with carboxylic acid functionality, which can participate in various chemical reactions and interactions with biological targets.

Recent studies have highlighted the potential of 2-(Quinolin-3-yl)propanoic acid in the development of novel drugs. For instance, research published in the Journal of Medicinal Chemistry has shown that this compound exhibits potent anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines such as TNF-α and IL-6. These findings suggest that 2-(Quinolin-3-yl)propanoic acid could be a promising lead compound for the treatment of inflammatory diseases such as rheumatoid arthritis and Crohn's disease.

In addition to its anti-inflammatory properties, 2-(Quinolin-3-yl)propanoic acid has also been investigated for its potential anticancer activity. A study published in the Cancer Research journal demonstrated that this compound can induce apoptosis in various cancer cell lines, including breast cancer and colon cancer cells. The mechanism of action involves the modulation of key signaling pathways such as the PI3K/Akt and MAPK pathways, which are frequently dysregulated in cancer cells.

The pharmacokinetic properties of 2-(Quinolin-3-yl)propanoic acid have also been studied extensively. Research has shown that this compound exhibits good oral bioavailability and favorable pharmacokinetic profiles, making it suitable for further development as an oral therapeutic agent. Additionally, the compound's low toxicity and high selectivity for its target proteins make it an attractive candidate for drug development.

To further explore the therapeutic potential of 2-(Quinolin-3-yl)propanoic acid, several preclinical studies have been conducted to evaluate its efficacy in animal models of disease. For example, a study published in the Nature Communications journal reported that treatment with this compound significantly reduced inflammation and tissue damage in a mouse model of colitis. These results provide strong evidence for the clinical translation of 2-(Quinolin-3-yl)propanoic acid.

In conclusion, 2-(Quinolin-3-yl)propanoic acid (CAS No. 1247842-46-1) is a promising compound with a wide range of biological activities and therapeutic potential. Its unique chemical structure and favorable pharmacological properties make it an attractive candidate for further research and development in the fields of medicinal chemistry and pharmaceutical science. As ongoing studies continue to uncover new insights into its mechanisms of action and therapeutic applications, it is likely that this compound will play an increasingly important role in the treatment of various diseases.

• 19656-83-8(2-(Quinolin-3-yl)acetic acid hydrochloride)
• 21070-37-1(L-α-(Indol-3-yl)propionsaeure)
• 21299-80-9(L-α-(Indol-3-yl)propionsaeure)
• 4314-59-4((2R)-(3-Indolyl)propionic acid)
• 2597-26-4(2-(1H-indol-3-yl)propanoic acid)
• 2770-92-5(2-(1H-indol-3-yl)-2-methyl-propanoic acid)
• 152150-04-4(2-(Quinolin-8-yl)acetic acid)
• 959585-30-9(2-(Quinolin-6-yl)propanoic acid)
• 154369-17-2(Methyl 2-(quinolin-3-yl)propanoate)
• 21168-40-1(2-(Quinolin-3-yl)acetic acid)